Literature DB >> 8493339

The properties of the long-term potentiation (LTP) in the superior colliculus.

Y Okada1.   

Abstract

(1) Postsynaptic potential (PSP) was recorded in the SGL of guinea pig SC slices after stimulation to the OL. (2) Tetanic stimulation (optimum parameter: 50 Hz in frequency, 20 sec in duration) to the OL induced LTP in the PSP of SGL. (3) NMDA-receptor antagonist MK801 inhibited the LTP occurrence but D-APV and gamma-DGG masked the appearance of LTP, suggesting that the mode of involvement of the NMDA receptor for LTP formation in the SC may be different from that reported in the hippocampus. (4) Protein kinase C inhibitors such as H-7, polymixin B and K-252a inhibited the maintenance of LTP. (5) Application of GABA prevented the occurrence of LTP and bicuculline facilitated the formation of LTP. (6) In in vivo preparations of the rat, the LTP in the SC was only elicited by tetanic stimulation to the optic nerve either when the visual cortical are ipsilateral to the SC tested was ablated or when picrotoxin was administered to the animal before tetanic stimulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8493339     DOI: 10.1016/s0079-6123(08)60376-3

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  3 in total

1.  NMDA antagonists in the superior colliculus prevent developmental plasticity but not visual transmission or map compression.

Authors:  L Huang; S L Pallas
Journal:  J Neurophysiol       Date:  2001-09       Impact factor: 2.714

2.  Preoperative red cell distribution width predicts postoperative cognitive dysfunction after coronary artery bypass grafting.

Authors:  Jing Wan; Peiwen Luo; Xiaonan Du; Hong Yan
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

Review 3.  Mechanisms of Plasticity in Subcortical Visual Areas.

Authors:  Maël Duménieu; Béatrice Marquèze-Pouey; Michaël Russier; Dominique Debanne
Journal:  Cells       Date:  2021-11-13       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.